Compare Intel Corp (INTC) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intel Corp vs Intuitive Surgical, Inc. — how do they compare? Intel Corp trades at $105.97 (market cap $487.82B), while Intuitive Surgical, Inc. trades at $351.54 (market cap $125.08B). The key difference: Intel Corp is far larger — about 3.9× Intuitive Surgical, Inc.'s market cap, and Intel Corp pays a 2.24% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| INTC | ISRG | |
|---|---|---|
Market Cap | $487.82B | $125.08B |
Volume | 43,552,012 | — |
Sector | Technology | Health |
52-Week High | $140.94 | $592.85 |
52-Week Low | $19.31 | $345.42 |
Enterprise Value | $500.07B | $116.45B |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intel (INTC) trades at $105.45, up 10.95% on the day, showing strong momentum ahead of Q2 2026 earnings. The stock exhibits a bearish technical signal but has beaten EPS estimates for three consecutive quarters. Revenue remains stable around $53B, though net income turned negative in 2025. Recent news highlights optimism around data center and AI segment growth, with a new partnership with Fortinet for security chips announced on July 21, 2026.
The outlook is mixed: analyst consensus suggests modest upside to a $110.33 price target, but high valuation ratios (P/E 904.17) and negative profitability metrics pose risks. Key catalysts include Q2 earnings results and execution of the turnaround strategy under CEO Lip-Bu Tan, while competitive pressures from Nvidia and AMD remain headwinds.
Intuitive Surgical (ISRG) trades at $350.06, down 1.34% on the day and near its 52-week low of $344.55. The stock is in a bearish technical trend despite strong fundamentals: Q2 2026 EPS beat estimates at $2.80 vs. $2.48 expected, revenue grew to $10.06B in 2025, and net income margin expanded to 28.45%. However, slowing U.S. procedure growth and a cautious 2026 outlook have pressured shares, with recent news highlighting a nearly 40% decline year-to-date.
The outlook remains mixed: robust profitability and a 69.6% analyst buy rating with a $504.56 consensus target suggest long-term value, but near-term risks include valuation concerns (P/E 40.5), competitive pressures, and macroeconomic headwinds. Investors face a divergence between solid execution and market sentiment driven by growth deceleration fears.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
